AEterna Zentaris Inc. Stock
Price
Target price
€1.85
€1.85
-1.090%
-0.02
-1.090%
€14.02
17.04.24 / Tradegate
WKN: A3DMG4 / Symbol: AEZS / Name: AEterna Zentaris / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
AEterna Zentaris Inc. Stock
We can see a decrease in the price for AEterna Zentaris Inc.. Compared to yesterday it has lost -€0.020 (-1.090%).
Currently there is a rather negative sentiment for AEterna Zentaris Inc. with 3 Buy predictions and 20 Sell predictions..
On the other hand, the target price of 14 € is above the current price of 1.85 € for AEterna Zentaris Inc., so the potential is actually 656.76%.
Our community identified positive and negative aspects for AEterna Zentaris Inc. stock for the coming years. 1 users see the criterium "Innovation" as a plus for the AEterna Zentaris Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of AEterna Zentaris Inc. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of AEterna Zentaris Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AEterna Zentaris Inc. | -1.090% | -4.145% | -3.141% | -34.629% | 5.956% | -89.905% | -98.024% |
| StageZero Life Sciences Ltd. | -20.510% | 0.000% | -32.609% | -66.304% | -31.111% | - | - |
| Satellos Bioscience Inc. | - | 0.613% | -17.172% | -6.818% | 18.841% | -74.375% | - |
| Antibe Therapeutics Inc. | 31.580% | 0.000% | -59.677% | -69.880% | -80.952% | -96.575% | -95.017% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-26
Upon examining the financial health of AEterna Zentaris, a player in the biotechnology and medical research industry, the immediate observation is that this company paints a picture of considerable financial challenges. With a modest market capitalization of approximately $8.61 million and an EBITDA which stands at a negative $15.70 million, one can infer that the company’s earnings before interest, taxes, depreciation, and amortization are not sufficient to cover these expenses, implying operational difficulties.
With a deep dive into the details, let us first elucidate the strengths or potential upsides in AEterna Zentaris' financial situation:
Conversely, a comprehensive analysis reveals a more extensive list of concerns:
Comments
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AEZS provided by MarketBeat